CD73 has been found to be overexpressed in many types of cancer cell lines and patient's biopsies including breast cancer, colorectal cancer, ovarian cancer, gastric cancer, and gallbladder cancer and associated with clinical characteristics, or prognosis of cancer patients (Tables 1 and 2). This evidence concerns the gene NT5E and gallbladder cancer.